Jacobson & Schmitt Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,487
Closed -$247K 68
2024
Q4
$247K Hold
2,487
0.05% 68
2024
Q3
$282K Sell
2,487
-37
-1% -$4.4K 0.06% 63
2024
Q2
$312K Buy
+2,524
New +$325K 0.07% 57
2024
Q1
Sell
-2,050
Closed -$223K 64
2023
Q4
$223K Sell
2,050
-183
-8% -$19K 0.06% 64
2023
Q3
$230K Buy
2,233
+183
+9% +$19.7K 0.07% 60
2023
Q2
$237K Hold
2,050
0.07% 58
2023
Q1
$218K Buy
+2,050
New +$221K 0.06% 60

Other funds holding MRK

Jacobson & Schmitt Advisors's MRK Position: Q1 2025 in Review

Jacobson & Schmitt Advisors sold out of Merck (MRK) in Q1 2025, closing a stake of 2,487 shares — an estimated $247K sold.

Jacobson & Schmitt Advisors first reported a position in MRK in Q1 2023 and held it in 7 quarters. The position peaked at $312K in Q2 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Jacobson & Schmitt Advisors reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Jacobson & Schmitt Advisors sold 2,487 Merck shares in Q1 2025, an estimated $247K.
  • Jacobson & Schmitt Advisors first reported a position in Merck in Q1 2023 and held it in 7 quarters.
  • Jacobson & Schmitt Advisors's Merck position peaked at $312K in Q2 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Jacobson & Schmitt Advisors's 13F filing for Q1 2025, filed 2 May 2025.